Subject: For action: Consultation of the EFSA-ECDC joint EU Summary Report on AMR in zoonotic and indicator bacteria from humans, animals and food 2023-2024
From: "FWD ECDC" <[email-masked]>
To: "Sabine Maritschnik" <[email-masked]>, "Christian Kornschober" <[email-masked]>, "Dieter Van Cauteren" <[email-masked]>, "Geraldine De Muylder" <[email-masked]>, "Borislava Tsafarova" <[email-masked]>, "Ivelina Zhivkova" <[email-masked]>, "Petya Stefanova" <[email-masked]>, "Iva Pem Novosel" <[email-masked]>,Sanja Kurečić-Filipović <[email-masked]>, "Aristos Aristodemou" <[email-masked]>, "Maria Meropi Charalambous" <[email-masked]>,Ondřej Daniel <ondrej.danie
Cc: "Austria Generic Email Box -" <[email-masked]>, "Sigrid Kiermayr" <[email-masked]>, "Koen Blot" <[email-masked]>, "Belgium Generic Email Box - Coordinating Competent Body" <[email-masked]>, "Julien Sohier" <[email-masked]>, "Zhivka Getsova" <[email-masked]>, "Iva Christova" <[email-masked]>, "Krunoslav Capak" <[email-masked]>, "Bernard Kaic" <[email-masked]>,Ivan Mlinarić <[email-masked]>, "Elisavet Constantinou" <[email-masked]>, <[email-masked]>, <[email-masked]>,Kamilla Grønborg
Date: Wed, 19 Nov 2025 22:49:11 +0200

Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu 
saatja korral palume linke ja faile mitte avada.

To: NFPs for FWD, OPCs for microbiology and epidemiology Salmonella 
isolates/salmonellosis, Campylobacter isolates/campylobacteriosis and 
shigellosis

Copy: National Coordinators

Dear colleagues,

We are pleased to provide you with a preliminary draft of the joint 
2023-2024 EFSA-ECDC EU Summary Report on AMR in zoonotic and indicator 
bacteria from humans, animals and food, for your review.

The report has been prepared under the ‘overview format’ covering the data 
from 2023 and 2024 in food producing animals and from 2024 for human data. 
The human sections in the report have been prepared by ECDC and the 
animal/food sections and comparison between sectors has been prepared by the 
EFSA external contractor, a consortium composed by two consultant companies 
SOLADIS and EFFOR-CVO and two public institutions DTU and SVA. EFSA and ECDC 
have reviewed this work.

Please note that report includes data from both 2023 and 2024 in food 
producing animals. This is done so that data from all food producing animal 
types will be covered in one report due to the rotating schedule of the 
sampling. The 2024 data are from poultry and 2023 data from pigs and calves. 
The data have been summarised but country specific results are available in 
the annexes.

All preliminary draft chapters and corresponding Appendix/Annex files, which 
together constitute the 2024 EUSR on AMR, are in PDF format and have been 
uploaded on the ECDC - FWDNet Collaboration Site in this folder: 
<https://ecdc365.sharepoint.com/:f:/r/teams/econ_fwd/Storage/Network%20consultations/EFSA-ECDC%20EU%20Summary%20Report%20on%20AMR%202023-2024?csf=1&web=1&e=9acBMw> 
EFSA-ECDC EU Summary Report on AMR 2023-2024. The ECDC - FWDNet 
Collaboration Site is accessible to the nominated FWD NFPs and OCPs.

The draft report contains information on AMR in isolates of Salmonella and 
Campylobacter from both human and animal/food sectors, while data on 
indicator E. coli and MRSA are only from animal and food isolates. A 
comparison of resistance levels in isolates from humans and animals is 
available before the discussion in both the Campylobacter and the Salmonella 
chapter. The country-specific data from humans are presented in Annex A.1 
(Salmonella) and B.1 (Campylobacter).

We have also prepared the 2024 FWD AMR data for Salmonella, Campylobacter 
and Shigella in the Nominated Users version of the 
<https://atlas.ecdc.europa.eu/protected/?Dataset=2011> Surveillance Atlas of 
Infectious Diseases for your review. For access, you need EpiPulse Cases 
access rights for SALMISO, CAMPISO or SHIG. PLEASE NOTE THAT YOU HAVE TO 
CLICK THE LINK TWICE IN ORDER TO GET TO THE NOMINATED ATLAS, i.e. return to 
this link and click again after you have logged in. To find the same numbers 
are those presented in the EFSA-ECDC AMR report, please select ‘Domestic and 
unknown’ and ‘Non-wild type or I+R isolates percentage’. Note that % 
resistance is only displayed if at least 10 isolates have been tested for 
the specific combination. Please let us know if you find any errors in the 
data displayed. The data will be published in the public Surveillance Atlas 
once the consultation has finished (unless changes are necessary).

Your review of the 2024 EUSR on AMR

We invite you to comment on the draft report and the analyses and 
conclusions made, and, in particular, to check that the information from 
your country is correctly presented in the report.

Send your review of the draft 2024 EUSR on AMR to [email-masked] 
<mailto:[email-masked]> . To this end, please provide comments using the 
Excel file attached. For each comment, please, complete the information in 
the excel template in the first tab. Every comment needs to be referenced by 
the chapter, the page number and the line number(s) of the text to which 
your comments refer to, or the number of the table or figure. In case you do 
not have comments for a specific chapter, please indicate this on the second 
tab of the Excel. To facilitate the reviewing process, please make sure to 
fill in your name, role, and your country.

We would very much appreciate to receive only one set of comments from each 
Member State/reporting country regarding the public health sector. 
Therefore, please, consider merging in the Excel file comments and requests 
from multiple reviewers from the same country. We kindly ask you to fill in 
all columns in the Excel file. Comments provided by other means (notes in 
the PDF, or Word file, or via email) will not be considered.

Please, provided us with your review as soon as possible and at the latest 
by Wednesday 3rd of December 2025. Note that EFSA will on their behalf 
consult their Scientific Network for Zoonoses monitoring data.

We take the opportunity to thank you so much for submitting your national 
AMR data that enabled us to prepare this Summary Report on AMR. We 
appreciate the extra efforts you had to make this year as we transitioned 
from TESSy to EpiPulse Cases.

We are looking forward to your comments and suggestions.

Best wishes,

Therese Westrell, ECDC FWD team

European Centre for Disease Prevention and Control (ECDC)Gustav III:s boulevard 40, 169 73 Solna, Sweden

Phone +46 (0)8 58 60 10 00

 <https://www.ecdc.europa.eu/> www.ecdc.europa.eu

Follow ECDC on:

 <http://www.facebook.com/ECDC.EU>

 <http://twitter.com/ecdc_eu>

 <http://www.linkedin.com/company/ecdc>

 <http://www.youtube.com/user/ECDCchannel>

Confidentiality Notice
If you are not the intended recipient of this message, you are hereby kindly 
requested, to, consecutively, refrain from disclosing its content to any 
third party, delete it and inform its sender of the erroneous transmittal.

Classified as ECDC NORMAL